David Macdonald has served in CEO and COO roles for over 25 years, most recently as the CEO at Agendia, and formerly as a Division President, COO and Vice President at Quest Diagnostics. He has an extensive successful track record in M&A integration, fundraising, strategic planning, and business plan execution in complex life science companies, large and small, public and private. Mr. Macdonald has been an invited speaker at a variety of industry events and has served on several industry Advisory Boards such as the Siemens Healthcare Diagnostics Strategic Advisory Board and California Med Tech Advisory Board. He has also held Board of Director roles at AdvaMedDx and the AdvaMed Emerging Growth Company Council (EGCC). David is a results-oriented, decisive leader with proven biotech industry expertise in wide variety of medical diagnostic systems, molecular diagnostics, personalized medicine, pharma collaboration, medical devices, research products, and laboratory services. He holds a BSBA degree in Management and Finance from Northeastern University and an MBA degree from Babson College with a focus on Marketing and Entrepreneurship.
Before founding First Light Biosciences, Don founded Rapid Micro Biosystems, a successful commercialization-stage venture-backed company. At both companies, he identified the target markets, invented the core scientific technology, built the founding teams, developed the product concepts, built IP portfolios, and led the development of product prototypes. He was Asst. Prof. (Brandeis U.) and earned a Ph.D. at Harvard (W. Gilbert) and a B.S. in Chemistry at the University of California (Berkeley).
Vice President, System Development and Operations
Joe Turgeon has been helping companies to commercialize and achieve operations excellence for more than twenty-five years, with a specific focus on product development, manufacturing and quality assurance for medical devices and diagnostic systems. This includes extensive start-up as well as large company experience in automated immunoassay diagnostics, lab-on-chip diagnostics, DNA sequencing, automated microscopy, wearable ultrasound therapeutic systems and automated disinfection equipment. Joe is a goal-driven leader that thrives on challenge and enjoys building and mentoring high performing teams. Joe’s experience includes; Dade-Behring Diagnostics, Quest Nichols Institute Diagnostics, 454 Life Sciences, Ikonisys, Zetroz and PCI Medical. He earned his Bachelor of Science in Manufacturing Engineering from Wentworth Institute and is a former U.S. Army Combat Engineer.
Chief Product Development Officer
Geoff joined the First Light Biosciences team to participate in the development of First Light’s automated medical diagnostic products for rapid, sensitive, and cost-effective detection of Healthcare Associated Infections (HAI). Before First Light Geoff joined OpGen, Inc. when OpGen acquired AdvanDx, Inc. His role included IVD instrument and assay development project responsibility and, as the management lead with executive responsibility, accomplishments included restructuring resources and re-engineering the quality system to meet FDA 21 CFR 820 (QSr) and ISO 13485 requirements. Geoff joined AdvanDx and was responsible for R&D strategy and new product development plans. His role included project responsibility, Program Management, Quality, Regulatory and Intellectual Property. At GenturaDx, Inc Geoff lead the development of the IDbox integrated sample-to-answer system (which is now the Aries system) enabling Gentura’s acquisition by Luminex Corporation. Geoff joined Osmetech plc (currently GenMark Diagnostics, Inc.) and participated in the acquisition of Clinical Micro Sensors and led the development, FDA clearance and launch of the electrochemistry-based Osmetech XT-8 multiplexed detection system (which is the predecessor to the GenMark ePLEX sample-to-answer system). He held various positions with bioMérieux, Inc. including Molecular Diagnostic Project Leader with global molecular diagnostic systems development responsibility. Geoff started his career with Analytab Products, Inc. (which was held by American Home Products) where he held various positions and developed his first FDA cleared manual identification kits. He is an author on 13 U.S. patents and received his Ph.D. in Microbiology from Colorado State University.
Chief Financial Officer
Mike Ellis previously served as the company’s acting CFO in a part time capacity for 4 years. He is a senior financial executive & attorney with over 30 years of financial and operational experience in the manufacturing and service industries. He has expertise in strategic and operational planning, cash management, technology licensing, budgeting and forecasting, cash management as well as debt and equity financing. Mike’s industry experience includes medical devices, high tech, R&D, software, and telecommunications.
VP Science and Assay Development
Jayson leads the assay development and science groups at First Light. Prior to joining, Jayson held leadership positions at 4 startup biotechnology companies including Helicos Biosciences, BioScale, and Sample6 where he was responsible for the development and commercialization of a variety of diagnostic technologies and assays. Jayson was a Howard Hughes Fellow at MIT and received his Ph.D. in Biochemistry and Molecular Genetics from Cornell University.
VP Software Engineering
Bruce Walsh leads the development of First Light’s products. He has more than 25 years of executive engineering management experience. Bruce was CTO at Spectel where he led a 100-person team and delivered strategy and products that led to the $103M sale of the company. As VP of Engineering at Data Translation, Bruce developed a critically acclaimed video product. He has a MSEE from Northeastern University and a BSEE from WPI.